" class="no-js "lang="en-US"> Marcus Schindler - Medtech Alert
Thursday, March 30, 2023
Marcus Schindler

Marcus Schindler

About Marcus Schindler

My team and I identify creative, innovative and differentiated science, technology platforms and compounds, build productive collaborations based on mutual respect and trust and also bring strategically relevant external innovation into Novo Nordisk’s R&D organisation- for the benefit of people with diabetes, obesity, cardiovascular diseases and NASH

Related Story

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

March 10 2022

Novo Nordisk today announced the expansion of its existing research collaboration in oral drug delivery […]

Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform

November 18 2021

Novo Nordisk today announced that it has entered into a definitive agreement to acquire Dicerna […]